Transenterix, inc. (TRXC)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current Assets
Cash and cash equivalents

21,816

9,598

22,106

23,302

25,545

21,061

41,748

97,743

87,634

91,217

24,483

29,741

13,086

24,165

42,518

64,609

53,511

38,449

52,893

71,112

28,376

34,766

44,344

52,566

4,160

10,014

23,829

1,026

1,834

8,896

118

1,301

3,979

298

328

594

3,032

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

6,191

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

0

9,973

22,904

51,790

39,670

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,469

-

1,104

-

-

907

-

-

-

-

-

-

-

Accounts receivable, net

951

620

2,352

5,669

8,531

8,560

5,669

2,210

1,837

1,536

253

1,665

1,828

621

616

77

79

76

78

8

53

133

38

96

52

188

294

5

9

536

9

8

-

-

-

-

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

9,464

8,321

-

2,250

4,247

3,615

6,625

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable - related-party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

63

62

-

45

35

25

66

58

76

64

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

106

-

83

158

134

143

131

135

117

Inventory, Net

9,829

10,653

13,657

20,091

15,197

10,941

10,242

11,040

11,644

10,817

11,273

-

-

7,883

-

-

-

-

3,435

-

-

-

267

438

651

701

766

1,482

1,594

1,382

1,687

1,646

506

-

86

91

91

Accounts receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

-

-

-

-

-

-

-

-

-

-

Interest receivable

-

-

22

30

34

26

51

104

101

80

19

13

10

12

15

19

12

6

6

1

1

1

-

2

73

68

10

-

-

16

-

-

-

-

-

-

-

Other Assets, Current

7,341

7,084

8,762

10,240

10,211

9,205

9,039

7,243

8,304

9,344

8,245

7,231

5,601

5,335

8,149

7,011

7,069

3,987

5,450

586

644

740

833

617

771

593

1,033

-

-

235

-

-

-

-

-

-

-

Total Current Assets

39,937

27,955

46,899

69,305

82,422

101,583

106,419

118,340

109,520

112,994

44,273

48,114

28,846

38,016

53,548

75,963

64,286

49,143

61,862

71,707

29,074

35,640

45,482

53,719

10,176

17,755

27,060

2,648

3,605

11,972

1,942

3,148

4,644

507

603

896

3,304

Restricted cash

925

969

698

712

578

590

663

750

6,779

6,389

-

-

-

10,425

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

6,386

6,419

10,432

-

10,353

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

266

274

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

289

-

-

0

0

250

250

250

250

-

375

-

-

-

-

-

-

-

-

-

-

-

Inventory, Noncurrent

7,201

7,594

9,336

-

-

0

-

-

-

-

-

-

-

-

-

-

1,028

709

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

-

375

-

-

375

-

-

-

-

-

-

-

Property and equipment, net

6,060

4,706

5,428

5,782

5,923

6,337

6,659

6,676

6,406

6,670

7,197

6,404

5,800

5,772

4,614

4,743

5,921

4,408

4,388

2,914

3,010

3,120

2,901

2,413

1,891

1,864

1,823

264

297

1,767

349

392

433

470

416

345

337

Intangible assets

-

-

-

-

-

-

-

-

-

-

-

37,170

36,015

-

41,260

42,571

46,892

46,898

63,866

1,991

2,116

2,241

2,366

2,491

2,616

2,741

2,866

-

-

3,241

-

-

-

-

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

17,276

16,161

-

16,972

16,811

17,191

16,511

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade names, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

6

7

-

8

8

9

10

10

-

-

0

-

-

-

-

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,197

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

0

79,904

79,509

80,131

70,669

70,813

71,954

71,368

71,038

70,310

68,984

68,697

69,948

69,756

132,394

130,869

116,054

93,842

93,842

93,842

93,842

93,842

93,842

93,842

93,670

-

-

0

-

-

-

-

-

-

-

Security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

-

2

2

2

2

2

2

2

Deferred financing costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

9

12

14

15

20

51

Other long term assets

2,168

2,489

2,584

2,818

1,695

203

224

259

283

192

279

146

114

63

63

63

64

64

59

90

52

18

71

72

105

127

129

2

2

205

9

11

14

16

17

22

53

Total Assets

84,230

74,779

97,634

203,378

216,976

239,307

227,559

242,747

246,175

250,251

183,724

185,839

166,352

176,249

197,032

210,196

267,776

248,602

268,432

170,550

128,351

135,111

144,920

152,795

108,889

116,714

125,933

2,914

3,904

17,560

2,300

3,551

5,091

993

1,036

1,263

3,694

Liabilities and Stockholders’ Equity
Current Liabilities
Accounts payable

4,047

3,579

3,403

7,039

4,756

4,433

2,785

4,108

3,614

3,771

2,625

2,219

3,269

3,984

2,596

2,002

3,140

4,450

4,394

1,606

2,278

1,768

3,265

3,616

-

1,804

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,858

-

2,567

615

1,039

521

860

1,146

798

469

415

347

221

Related party payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

52

96

-

-

-

-

-

-

-

-

Accrued expenses

8,026

8,553

8,094

8,182

7,044

9,619

7,432

10,270

8,222

10,974

8,926

8,221

7,262

8,206

7,246

7,344

6,663

7,395

6,160

2,259

1,626

1,769

1,756

1,906

1,531

1,406

1,078

-

-

538

-

-

-

-

-

-

-

Deferred revenue – current portion

903

818

884

897

1,618

1,733

1,270

-

-

1,088

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred gain on sale of SurgiBot assets

-

-

-

-

-

-

-

-

-

7,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

1,083

1,018

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration – current portion

72

73

71

74

70

72

555

547

760

719

6,958

6,918

6,250

10,502

11,325

12,500

13,300

12,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred consideration - MST Acquisition

-

-

0

6,310

6,044

5,962

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable – current portion, net of debt discount

-

-

-

-

-

-

-

-

6,583

4,788

-

-

8,172

7,997

7,826

7,658

7,493

6,727

4,780

2,487

1,540

610

-

4,052

3,965

3,879

3,795

-

-

1,519

-

-

-

-

0

7

49

Stockholder loans, including accrued interest ( Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Total Current Liabilities

13,048

13,023

12,452

22,502

19,532

21,819

12,042

16,008

20,197

28,840

18,509

17,358

24,953

30,689

28,993

29,504

30,596

31,072

15,334

6,352

5,444

4,147

5,021

9,574

7,354

7,089

7,440

667

1,135

2,578

860

1,146

798

469

415

354

270

Long Term Liabilities
Deferred revenue – less current portion

13

27

46

68

-

109

131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration – less current portion

2,068

1,011

877

12,521

11,565

10,565

11,549

12,915

12,285

11,699

11,446

11,108

12,550

12,298

13,875

12,800

11,056

11,000

24,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

109

-

-

-

-

-

-

-

Notes payable, net of debt discount

-

-

15,343

29,528

29,267

28,937

19,106

18,952

6,863

8,385

12,825

12,896

2,885

4,995

7,059

9,080

11,057

12,990

14,884

7,427

8,360

9,175

9,871

2,532

3,578

4,602

5,604

-

-

8,481

-

-

-

-

-

-

-

Warrant liabilities

73

2,388

1,600

2,214

4,742

4,636

15,044

22,708

11,745

14,090

31,156

11,041

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net deferred tax liabilities

649

1,392

1,960

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net deferred tax liabilities

-

-

-

3,164

4,000

4,720

5,624

6,446

7,727

8,389

9,223

9,614

9,697

10,397

11,971

12,920

14,210

16,263

21,218

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long term liabilities

1,217

1,403

1,590

1,894

1,104

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Liabilities

17,068

19,244

33,868

71,891

70,210

70,786

63,496

77,029

58,817

71,403

83,159

62,017

50,085

58,379

61,898

64,304

66,919

71,325

75,736

13,779

13,804

13,322

14,892

12,106

10,932

11,691

13,044

-

-

11,168

-

-

-

-

-

-

-

Stockholders loans, including accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

300

-

-

2,523

1,107

0

0

Commitments and Contingencies (Note 18)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ Equity
Common stock $0.001 par value, 750,000,000 shares authorized at March 31, 2020 and December 31, 2019; 47,078,314 and 20,691,301 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

47

21

255

217

217

17

212

207

201

199

155

148

123

115

115

115

109

100

100

82

64

63

63

63

49

49

168

62

62

5

49

49

49

28

28

28

28

Preferred stock, $0.01 par value, 25,000,000 shares authorized, including 7,937,057 and 0 shares of Series A Convertible Preferred Stock at March 31, 2020 and December 31, 2019, and 4,884,117 and 0 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

49

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Additional paid-in capital

749,506

720,484

716,420

682,736

679,084

676,572

664,439

645,332

628,332

621,261

468,150

455,853

439,038

426,609

425,041

423,544

396,098

363,280

362,313

312,073

260,519

257,642

257,802

256,956

203,651

203,238

172,757

33,223

32,785

1,288

29,396

29,283

29,170

20,762

20,667

20,569

20,427

Accumulated deficit

-680,200

-663,600

-649,900

-552,100

-531,924

-509,406

-502,965

-482,759

-448,511

-447,640

-371,484

-332,971

-318,258

-302,844

-288,852

-275,908

-195,777

-182,864

-169,285

-155,384

-146,036

-135,916

-127,837

-116,330

-105,743

-98,264

-

-

-

-

-

-

-

-

-

-

-

Treasury stock at cost, 0 and 93,679 shares at December 31, 2017 and 2016, respectively

-

-

-

-

-

-

-

-

-

-

2

2

-

241

203

203

203

73

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-2,242

-1,370

-3,041

629

-611

1,338

2,377

2,938

7,336

5,028

3,746

794

-4,636

-5,769

-967

-1,656

630

-3,166

-429

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

90,233

31,038

30,078

69,906

28,305

26,927

24,926

22,789

21,181

19,688

17,031

Total Stockholders’ Equity

67,162

55,535

63,766

131,487

146,766

168,521

164,063

165,718

187,358

178,848

100,565

123,822

116,267

117,870

135,134

145,892

200,857

177,277

192,696

156,771

114,547

121,789

130,028

140,689

97,957

105,023

112,889

2,247

2,769

-68,613

1,140

2,405

4,293

-1,999

-486

909

3,424

Total Liabilities and Stockholders’ Equity

84,230

74,779

97,634

203,378

216,976

239,307

227,559

242,747

246,175

250,251

183,724

185,839

166,352

176,249

197,032

210,196

267,776

248,602

268,432

170,550

128,351

135,111

144,920

152,795

108,889

116,714

125,933

2,914

3,904

17,560

2,300

3,551

5,091

993

1,036

1,263

3,694

Intellectual property, net
Intangible assets

27,939

28,596

30,289

34,190

36,322

39,716

-

-

-

52,638

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In-Process Research and Development
Intangible assets

0

2,470

2,400

10,667

10,527

10,747

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-